| 125.59 1.68 (1.36%) | 04-10 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 147.51  |
1-year : | 172.3 |
| Resists | First : | 126.3 |
Second : | 147.51 |
| Pivot price | 118.92 |
|||
| Supports | First : | 116.11 |
Second : | 109.81 |
| MAs | MA(5) : | 121.7 |
MA(20) : | 119.35 |
| MA(100) : | 115.76 |
MA(250) : | 100.57 |
|
| MACD | MACD : | 0.3 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 95.5 |
D(3) : | 85.1 |
| RSI | RSI(14): 61.3 |
|||
| 52-week | High : | 127.13 | Low : | 70.96 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ EIS ] has closed below upper band by 4.8%. Bollinger Bands are 63.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 126.33 - 126.7 | 126.7 - 127.12 |
| Low: | 123.68 - 124.14 | 124.14 - 124.66 |
| Close: | 124.67 - 125.36 | 125.36 - 126.14 |
The iShares MSCI Israel ETF seeks to track the investment results of a broad-based index composed of Israeli equities.
Fri, 10 Apr 2026
EIS Stock Price, Quote & Chart | ISHARES MSCI ISRAEL ETF (NYSEARCA:EIS) - ChartMill
Sun, 29 Mar 2026
How Ishares Msci Israel Etf (EIS) Affects Rotational Strategy Timing - Stock Traders Daily
Tue, 17 Feb 2026
Why Is Teva Pharmaceutical Stock Trading Higher Today? - Sanofi (NASDAQ:SNY), Teva Pharmaceutical Indus - Benzinga
Mon, 09 Feb 2026
Israel’s Equity Surge: Analyzing the iShares MSCI Israel ETF Trajectory - AD HOC NEWS
Fri, 23 Jan 2026
EIS Forecast — Price Prediction for 2026. Should I Buy EIS? - Intellectia AI
Sun, 28 Dec 2025
The Best Year For Foreign Stocks Since 2009, EIS Leads The Charge (Rating Upgrade) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|